AbbVie (NYSE: ABBV), has brought together leading local and international experts to discuss New Zealand’s progress towards the World Health Organization (WHO) 2030 goal for hepatitis C (HCV) elimination
The National Hepatitis C Awareness Campaign announced today will also see the expansion of more pharmacies getting involved in the test-and-treat programme which has been running in 64 pharmacies over the past 12 monthsÂ